Skip to main content

SZ 469 (Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base))

Pill with imprint SZ 469 is White, Elliptical/Oval and has been identified as Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base). It is supplied by Sandoz Inc.

Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 4 mg / 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 469

Glimepiride and Pioglitazone Hydrochloride

SZ 469
4 mg / 30 mg (base)
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc.
National Drug Code (NDC)
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, polysorbate 80, microcrystalline cellulose

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.